CPPD metabolic associations — SCE Rheumatology MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Screen for haemochromatosis, hyperparathyroidism and metabolic causes
Explanation lettering: B = shown as A · D = shown as B · A = shown as D
Screen for haemochromatosis, hyperparathyroidism and metabolic causes is best because early or recurrent CPPD should prompt assessment for associated metabolic disorders including haemochromatosis and hyperparathyroidism. A is less suitable because anti-dsDNA assesses lupus rather than CPPD associations; C is less suitable because biologic therapy is not first-line and should not precede metabolic evaluation; D is less suitable because HLA-B27 is not the key CPPD test; E is less suitable because temporal artery biopsy is unrelated. Clinical pearl: CPPD in a relatively young patient is a clue to look for secondary causes.
Reference: Oxford Textbook of Rheumatology; BSR gout guideline